Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk.

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sanchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, Rissanen H, Yeap BB, Flicker L, Almeida OP, Wong YYE, Chan JM, Giovannucci EL, Stampfer MJ, Ursin G, Gislefoss RE, Bjørge T, Meyer HE, Blomhoff R, Tsugane S, Sawada N, English DR, Eyles DW, Heath AK, Williamson EJ, Manjer J, Malm J, Almquist M, Le Marchand L, Haiman CA, Wilkens LR, Schenk JM, Tangen CM, Black A, Cook MB, Huang WY, Ziegler RG, Martin RM, Hamdy FC, Donovan JL, Neal DE, Touvier M, Hercberg S, Galan P, Deschasaux M, Key TJ, Allen NE.

Cancer Res. 2018 Nov 13. pii: canres.2318.2018. doi: 10.1158/0008-5472.CAN-18-2318. [Epub ahead of print]

PMID:
30425058
2.

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study.

Ramin C, May BJ, Roden RBS, Orellana MM, Hogan BC, McCullough MS, Petry D, Armstrong DK, Visvanathan K.

Breast Cancer Res. 2018 Nov 13;20(1):134. doi: 10.1186/s13058-018-1061-4.

3.

Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists.

Song Y, Nigro J, Yu L, Congiu M, Skinner N, Thompson A, Visvanathan K.

J Immunol Methods. 2018 Nov 3. pii: S0022-1759(18)30221-7. doi: 10.1016/j.jim.2018.11.003. [Epub ahead of print]

PMID:
30395817
4.

Consumer credit, chronic disease and risk behaviours.

Dean LT, Knapp EA, Snguon S, Ransome Y, Qato DM, Visvanathan K.

J Epidemiol Community Health. 2018 Oct 15. pii: jech-2018-211160. doi: 10.1136/jech-2018-211160. [Epub ahead of print]

5.

Serological response to Helicobacter pylori proteins associate with risk of colorectal cancer among diverse populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35088-1. doi: 10.1053/j.gastro.2018.09.054. [Epub ahead of print]

PMID:
30296434
6.

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.

Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM.

Cancer Prev Res (Phila). 2018 Nov;11(11):697-706. doi: 10.1158/1940-6207.CAPR-18-0009. Epub 2018 Sep 19.

PMID:
30232083
7.

Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.

Purdue MP, Lan Q, Hoffman-Bolton J, Hildesheim A, Callahan CL, Strickland P, Visvanathan K, Rothman N.

Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879. [Epub ahead of print]

PMID:
30230539
8.

"It still affects our economic situation": long-term economic burden of breast cancer and lymphedema.

Dean LT, Moss SL, Ransome Y, Frasso-Jaramillo L, Zhang Y, Visvanathan K, Nicholas LH, Schmitz KH.

Support Care Cancer. 2018 Aug 18. doi: 10.1007/s00520-018-4418-4. [Epub ahead of print]

PMID:
30121786
9.

BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.

Gross AL, Blot WJ, Visvanathan K.

JAMA. 2018 Aug 14;320(6):597-598. doi: 10.1001/jama.2018.8258. No abstract available.

PMID:
30120466
10.

Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Waterboer T, Pawlita M, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1186-1194. doi: 10.1158/1055-9965.EPI-18-0249. Epub 2018 Jul 23.

PMID:
30038049
11.

Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.

Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ.

JAMA Oncol. 2018 Nov 1;4(11):e181771. doi: 10.1001/jamaoncol.2018.1771. Epub 2018 Nov 8.

PMID:
29931120
12.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA.

J Natl Cancer Inst. 2018 Jun 14. doi: 10.1093/jnci/djy087. [Epub ahead of print]

PMID:
29912394
13.

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Larose TL, Guida F, Fanidi A, Langhammer A, Kveem K, Stevens VL, Jacobs EJ, Smith-Warner SA, Giovannucci E, Albanes D, Weinstein SJ, Freedman ND, Prentice R, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Hodge AM, Giles GG, Severi G, Johansson M, Grankvist K, Wang R, Yuan JM, Gao YT, Koh WP, Shu XO, Zheng W, Xiang YB, Li H, Lan Q, Visvanathan K, Hoffman Bolton J, Ueland PM, Midttun Ø, Caporaso N, Purdue M, Sesso HD, Buring JE, Lee IM, Gaziano JM, Manjer J, Brunnström H, Brennan P, Johansson M.

Int J Epidemiol. 2018 Jun 12. doi: 10.1093/ije/dyy100. [Epub ahead of print]

PMID:
29901778
14.

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV Jr, Larsson SC, Mackenzie GG, Schouten LJ, Sandler DP, O'Brien K, Patel AV, Peters U, Prizment A, Robien K, Setiawan WV, Swerdlow A, van den Brandt PA, Weiderpass E, Wilkens LR, Wolk A, Wentzensen N, Tworoger SS; Ovarian Cancer Cohort Consortium (OC3).

J Natl Cancer Inst. 2018 May 31. doi: 10.1093/jnci/djy100. [Epub ahead of print]

PMID:
29860330
15.

Social factors matter in cancer risk and survivorship.

Dean LT, Gehlert S, Neuhouser ML, Oh A, Zanetti K, Goodman M, Thompson B, Visvanathan K, Schmitz KH.

Cancer Causes Control. 2018 Jul;29(7):611-618. doi: 10.1007/s10552-018-1043-y. Epub 2018 May 30.

16.

Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation.

Sood S, Haifer C, Yu L, Pavlovic J, Gow PJ, Jones RM, Visvanathan K, Angus PW, Testro AG.

Transpl Infect Dis. 2018 Oct;20(5):e12934. doi: 10.1111/tid.12934. Epub 2018 Jun 19.

PMID:
29809312
17.

Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.

Huang BZ, Tsilidis KK, Smith MW, Hoffman-Bolton J, Visvanathan K, Platz EA, Joshu CE.

Mol Carcinog. 2018 Oct;57(10):1278-1288. doi: 10.1002/mc.22842. Epub 2018 Jun 5.

PMID:
29802748
18.

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.

Igusa T, Hummers LK, Visvanathan K, Richardson C, Wigley FM, Casciola-Rosen L, Rosen A, Shah AA.

Ann Rheum Dis. 2018 Aug;77(8):1179-1186. doi: 10.1136/annrheumdis-2018-212999. Epub 2018 Apr 20.

PMID:
29678941
19.

Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine.

Bolther M, Andersen KLD, Tolstrup M, Visvanathan K, Woolley I, Skinner N, Millen R, Warner N, Østergaard L, Jensen-Fangel S.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1483-1488. doi: 10.1080/21645515.2018.1441653. Epub 2018 Apr 11.

PMID:
29474139
20.

Social comparisons and quality of life following a prostate cancer diagnosis.

Umstead KL, Kalia SS, Madeo AC, Erby LH, Blank TO, Visvanathan K, Roter DL.

J Psychosoc Oncol. 2018 May-Jun;36(3):350-363. doi: 10.1080/07347332.2017.1417950. Epub 2018 Feb 9.

PMID:
29424665
21.

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT.

Nat Commun. 2018 Feb 8;9(1):556. doi: 10.1038/s41467-018-02942-5.

22.

Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA.

Dean LT, Schmitz KH, Frick KD, Nicholas LH, Zhang Y, Subramanian SV, Visvanathan K.

J Cancer Surviv. 2018 Jun;12(3):306-315. doi: 10.1007/s11764-017-0669-1. Epub 2018 Jan 25.

23.

Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study.

Heriot GS, Tong SYC, Cheng AC, Thevarajan I, Levinson MR, Visvanathan K, Liew D.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):469-474. doi: 10.1007/s10096-018-3192-z. Epub 2018 Jan 22.

PMID:
29357050
24.

Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study.

Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ.

Int J Cancer. 2018 Jun 1;142(11):2227-2233. doi: 10.1002/ijc.31250. Epub 2018 Jan 23.

PMID:
29318620
25.

Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A.

Int J Cancer. 2018 Jun 1;142(11):2215-2226. doi: 10.1002/ijc.31249. Epub 2018 Feb 8.

PMID:
29315564
26.

Precancerous Lesions of Ovarian Cancer-A US Perspective.

Visvanathan K, Wang TL, Shih IM.

J Natl Cancer Inst. 2018 Jul 1;110(7):692-693. doi: 10.1093/jnci/djx269. No abstract available.

PMID:
29281080
27.

Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC Cancer.

Joshu CE, Barber JR, Coresh J, Couper DJ, Mosley TH, Vitolins MZ, Butler KR, Nelson HH, Prizment AE, Selvin E, Tooze JA, Visvanathan K, Folsom AR, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):295-305. doi: 10.1158/1055-9965.EPI-17-0696. Epub 2017 Dec 20.

PMID:
29263187
28.

Impaired functional vitamin B6 status is associated with increased risk of lung cancer.

Theofylaktopoulou D, Midttun Ø, Ueland PM, Meyer K, Fanidi A, Zheng W, Shu XO, Xiang YB, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough MM, Weinstein SJ, Albanes D, Ziegler R, Freedman ND, Langhammer A, Hveem K, Naess M, Sesso HD, Gaziano JM, Buring JE, Lee IM, Severi G, Zhang X, Stampfer MJ, Han J, Smith-Warner SA, Zeleniuch-Jacquotte A, Le Marchand L, Yuan JM, Wang R, Butler LM, Koh WP, Gao YT, Rothman N, Ericson U, Sonestedt E, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ulvik A.

Int J Cancer. 2018 Jun 15;142(12):2425-2434. doi: 10.1002/ijc.31215. Epub 2018 Jan 4.

PMID:
29238985
29.

Association Between Physicians' Experiences With Members of Their Social Network and Efforts to Reduce Breast Cancer Screening.

Pollack CE, Radhakrishnan A, Parker AM, Chen X, Visvanathan K, Nowak SA.

JAMA Intern Med. 2018 Jan 1;178(1):148-151. doi: 10.1001/jamainternmed.2017.6871. No abstract available.

PMID:
29204657
30.

Linking physician attitudes to their breast cancer screening practices: A survey of US primary care providers and gynecologists.

Radhakrishnan A, Nowak SA, Parker AM, Visvanathan K, Pollack CE.

Prev Med. 2018 Feb;107:90-102. doi: 10.1016/j.ypmed.2017.11.010. Epub 2017 Nov 17.

PMID:
29155227
31.

Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).

Fanidi A, Muller DC, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Thomsen CA, Pettinger M, Cai Q, Blot WJ, Wu J, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Giovannucci E, Giles GG, Hodge AM, Severi G, Johansson M, Grankvist K, Langhammer A, Krokstad S, Næss M, Wang R, Gao YT, Butler LM, Koh WP, Shu XO, Xiang YB, Li H, Zheng W, Lan Q, Visvanathan K, Bolton JH, Ueland PM, Midttun Ø, Ulvik A, Caporaso NE, Purdue M, Ziegler RG, Freedman ND, Buring JE, Lee IM, Sesso HD, Gaziano JM, Manjer J, Ericson U, Relton C, Brennan P, Johansson M.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx119.

32.

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF.

Int J Cancer. 2018 Jan 15;142(2):262-270. doi: 10.1002/ijc.31058. Epub 2017 Oct 4.

PMID:
28921520
33.

End-of-life prescribing of aspirin in patients with breast or colorectal cancer.

Murphy L, Brown C, Smith A, Cranfield F, Sharp L, Visvanathan K, Bennett K, Barron TI.

BMJ Support Palliat Care. 2017 Aug 24. pii: bmjspcare-2017-001370. doi: 10.1136/bmjspcare-2017-001370. [Epub ahead of print]

PMID:
28838931
34.

Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease.

Shah AA, Rosen A, Hummers LK, May BJ, Kaushiva A, Roden RBS, Armstrong DK, Wigley FM, Casciola-Rosen L, Visvanathan K.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):71-74. Epub 2017 Jun 19.

35.

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM, Jones ME, Adami HO, Agnoli C, Baglietto L, Bernstein L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Butler L, Chen Y, Doody MM, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Lund E, Ma H, Merritt MA, Milne RL, Navarro C, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Sandler DP, Swerdlow AJ.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1360-1369. doi: 10.1158/1055-9965.EPI-17-0246. Epub 2017 Jun 9. Review.

36.

Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations.

Midttun Ø, Theofylaktopoulou D, McCann A, Fanidi A, Muller DC, Meyer K, Ulvik A, Zheng W, Shu XO, Xiang YB, Prentice R, Thomson CA, Pettinger M, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, Langhammer A, Hveem K, Næss M, Sesso HD, Gaziano JM, Buring JE, Lee IM, Severi G, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Zeleniuch-Jacquotte A, le Marchand L, Yuan JM, Butler LM, Koh WP, Wang R, Gao YT, Ericson U, Sonestedt E, Ziegler RG, Freedman ND, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ueland PM.

Am J Clin Nutr. 2017 Jun;105(6):1314-1326. doi: 10.3945/ajcn.116.151241. Epub 2017 Apr 19.

37.

Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.

Cameron DR, Lin YH, Trouillet-Assant S, Tafani V, Kostoulias X, Mouhtouris E, Skinner N, Visvanathan K, Baines SL, Howden B, Monk IR, Laurent F, Stinear TP, Howden BP, Peleg AY.

Clin Microbiol Infect. 2017 Oct;23(10):767-773. doi: 10.1016/j.cmi.2017.03.027. Epub 2017 Apr 7.

38.

Physician Breast Cancer Screening Recommendations Following Guideline Changes: Results of a National Survey.

Radhakrishnan A, Nowak SA, Parker AM, Visvanathan K, Pollack CE.

JAMA Intern Med. 2017 Jun 1;177(6):877-878. doi: 10.1001/jamainternmed.2017.0453. No abstract available.

39.

Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study.

Cronin KM, Poy Lorenzo YS, Olenski ME, Bloch AE, Visvanathan K, Waters MJ, Buising KL.

J Hosp Infect. 2017 Jun;96(2):111-115. doi: 10.1016/j.jhin.2017.02.010. Epub 2017 Feb 16.

PMID:
28389093
40.

Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.

Ose J, Poole EM, Schock H, Lehtinen M, Arslan AA, Zeleniuch-Jacquotte A, Visvanathan K, Helzlsouer K, Buring JE, Lee IM, Tjønneland A, Dossus L, Trichopoulou A, Masala G, Onland-Moret NC, Weiderpass E, Duell EJ, Idahl A, Travis RC, Rinaldi S, Merritt MA, Trabert B, Wentzensen N, Tworoger SS, Kaaks R, Fortner RT.

Cancer Res. 2017 Jul 15;77(14):3951-3960. doi: 10.1158/0008-5472.CAN-16-3322. Epub 2017 Apr 5.

41.

Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.

Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sánchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjønneland A, Trichopoulou A, Tworoger S, Visvanathan K, Krogh V, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF.

Fertil Steril. 2017 Apr;107(4):1012-1022.e2. doi: 10.1016/j.fertnstert.2017.02.105.

42.

Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.

Visvanathan K, Levit LA, Raghavan D, Hudis CA, Wong S, Dueck A, Lyman GH.

J Clin Oncol. 2017 Jun 1;35(16):1845-1854. doi: 10.1200/JCO.2017.72.6414. Epub 2017 Mar 30.

PMID:
28358653
43.

Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.

Barton V, Armeson K, Hampras S, Ferris LK, Visvanathan K, Rollison D, Alberg AJ.

Arch Dermatol Res. 2017 May;309(4):243-251. doi: 10.1007/s00403-017-1724-5. Epub 2017 Mar 11. Review.

44.

Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.

Ose J, Schock H, Poole EM, Lehtinen M, Visvanathan K, Helzlsouer K, Buring JE, Lee IM, Tjønneland A, Boutron-Ruault MC, Trichopoulou A, Mattiello A, Onland-Moret NC, Weiderpass E, Sánchez MJ, Idahl A, Travis RC, Rinaldi S, Merritt MA, Wentzensen N, Tworoger SS, Kaaks R, Fortner RT.

Cancer Causes Control. 2017 May;28(5):429-435. doi: 10.1007/s10552-017-0852-8. Epub 2017 Feb 16.

45.

A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation.

Sood S, Haifer C, Yu L, Pavlovic J, Churilov L, Gow PJ, Jones RM, Angus PW, Visvanathan K, Testro AG.

Liver Transpl. 2017 Apr;23(4):487-497. doi: 10.1002/lt.24730.

46.

Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients.

Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG.

World J Hepatol. 2016 Dec 18;8(35):1569-1575. doi: 10.4254/wjh.v8.i35.1569.

47.

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, Miller DV, Armstrong DK, Connolly RM, Fetting JH, Miller RS, Park BH, Stearns V, Visvanathan K, Wolff AC, Cope L.

J Clin Oncol. 2016 Dec 20;34(36):4390-4397. Epub 2016 Oct 31.

48.

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.

Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MP, Gavin A, Friis S, Sharp L, Bennett K.

Breast Cancer Res. 2016 Dec 1;18(1):119.

49.

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Visvanathan K, Fackler MS, Zhang Z, Lopez-Bujanda ZA, Jeter SC, Sokoll LJ, Garrett-Mayer E, Cope LM, Umbricht CB, Euhus DM, Forero A, Storniolo AM, Nanda R, Lin NU, Carey LA, Ingle JN, Sukumar S, Wolff AC.

J Clin Oncol. 2017 Mar;35(7):751-758. doi: 10.1200/JCO.2015.66.2080. Epub 2016 Nov 21.

50.

Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.

Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, Wolff RK, John EM, Slattery ML.

Breast Cancer Res Treat. 2017 Jan;161(2):321-331. doi: 10.1007/s10549-016-4048-9. Epub 2016 Nov 11.

Supplemental Content

Loading ...
Support Center